NVP-BEZ235, A DUAL PI3K/MTOR INHIBITOR SYNERGISTICALLY POTENTIATES ANTITUMOR EFFECT OF CISPLATIN IN BLADDER CANCER CELLS

被引：0
|
作者：
Park, Hong Seok
Yoon, Cheol Yong
Cheon, Jun
机构：
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2014年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A206 / A206
页数：1
相关论文
共 50 条
  • [21] The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells
    Li, Chuntuan
    Xin, Pengliang
    Xiao, Huifang
    Zheng, Yan
    Huang, Yuanling
    Zhu, Xiongpeng
    CANCER CELL INTERNATIONAL, 2015, 15
  • [22] Effect of the combination of the dual mTOR/pI3K inhibitor NVP-BEZ235 with gemcitabine on growth inhibition in pancreatic cancer cells in vitro and in vivo
    Maute, Luise
    Wicht, Johannes
    Zoernig, Martin
    Niederhagen, Manuel
    Bergmann, Lothar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells
    Chuntuan Li
    Pengliang Xin
    Huifang Xiao
    Yan Zheng
    Yuanling Huang
    Xiongpeng Zhu
    Cancer Cell International, 15
  • [24] Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235
    Xie, Chencheng
    Freeman, Matthew J.
    Lu, Huarui
    Wang, Xiaohong
    Forster, Colleen L.
    Sarver, Aaron L.
    Hallstrom, Timothy C.
    ONCOTARGET, 2017, 8 (24) : 38084 - 38098
  • [25] The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma
    Oishi, Tetsuro
    Itamochi, Hiroaki
    Kudoh, Akiko
    Nonaka, Michiko
    Kato, Misaki
    Nishimura, Mayumi
    Oumi, Nao
    Sato, Seiya
    Naniwa, Jun
    Sato, Shinya
    Shimada, Muneaki
    Kigawa, Junzo
    Harada, Tasuku
    ONCOLOGY REPORTS, 2014, 32 (02) : 553 - 558
  • [26] Drug irradiation schedule is decisive for radiosensitization by the novel dual PI3K and mTOR inhibitor NVP-BEZ235
    Kuger, S.
    Graus, D.
    Brendtke, R.
    Lutyj, P.
    Soukhoroukov, V
    Flentje, M.
    Djuzenova, C. S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 67 - 67
  • [27] Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib
    Roulin, Didier
    Waselle, Laurent
    Dormond-Meuwly, Anne
    Dufour, Marc
    Demartines, Nicolas
    Dormond, Olivier
    MOLECULAR CANCER, 2011, 10
  • [28] Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in hepatocellular carcinoma cell lines
    Masuda, Mitsuhiro
    Shimomura, Manami
    Kobayashi, Ken
    Kojima, Shuji
    Nakatsura, Tetsuya
    ONCOLOGY REPORTS, 2011, 26 (05) : 1273 - 1279
  • [29] Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib
    Didier Roulin
    Laurent Waselle
    Anne Dormond-Meuwly
    Marc Dufour
    Nicolas Demartines
    Olivier Dormond
    Molecular Cancer, 10
  • [30] Synergistic antitumor effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with cisplatin on drug-resistant non-small cell lung cancer cell
    Zhu, Hao
    Shi, Yuhuan
    Jiao, Xiuxiu
    Yang, Gang
    Wang, Rong
    Yuan, Yongfang
    ONCOLOGY LETTERS, 2020, 20 (06)
12345